Search results
Setting the standard for gene therapy. For more than a decade, we’ve forged new paths for gene therapies and are improving and advancing at every step. We have the largest and deepest ex-vivo gene therapy data set in the world—driving the field forward, but we aren’t doing this alone. We learn from the realities of others.
- Careers
We encourage all job seekers to take steps to educate...
- Investors & Media
bluebird bio is pursuing curative gene therapies to give...
- About Us
Accessed April 2022. bluebird bio is pioneering gene therapy...
- Our Therapies
Personalized support focused on the needs of each patient...
- Contact Us
bluebird bio Headquarters. 455 Grand Union Boulevard...
- Our Focus
Our goal is to provide hope for a better life – and more...
- Our Science
Our Science: Leading the Gene Therapy Revolution | bluebird...
- Beta-Thalassemia
Healthy red blood cells are vitally important for fueling...
- Careers
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include ...
bluebird bio, Inc., based in Somerville, Massachusetts, is a biotechnology company that develops gene therapies for severe genetic disorders. [1] The company's only - in the European Union (EU) - approved drug is betibeglogene autotemcel (Zynteglo), which treats transfusion-dependent beta thalassemia (TDT), a rare genetic blood disorder, and ...
- April 16, 1992; 31 years ago
- Somerville, Massachusetts, U.S.
- 518 (January 2022)
2 days ago · Bluebird bio ( NASDAQ: BLUE) shares climbed on Thursday, even as its rival CRISPR Therapeutics ( NASDAQ: CRSP) indicated a faster rollout in the race to market two recently approved gene therapies ...
People also ask
Who is Bluebird Bio?
Who is Bluebird gene therapy?
What is Bluebird Bio's investigational gene therapy?
Is Bluebird Bio (Blue) a good stock to buy?
